Cosciens Biopharma Inc (CSCIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 31,990 | 38,100 | N/A | 10,270 | 9,350 |
| Marketable Securities | 1,930 | 0 | N/A | 31,110 | 51,660 |
| Receivables | 4,550 | 3,430 | N/A | 9,210 | 9,770 |
| Inventories | 3,310 | 4,410 | N/A | 5,400 | 5,360 |
| Other current assets | 2,390 | 3,070 | 4,090 | 3,590 | 25,580 |
| TOTAL | $44,170 | $49,010 | $4,090 | $59,580 | $101,720 |
| Non-Current Assets | |||||
| PPE Net | 3,090 | 4,350 | N/A | 7,460 | 13,430 |
| Investments And Advances | 0 | 0 | 0 | 0 | 57,120 |
| Other Non-Current Assets | 29,290 | 32,880 | 39,920 | 56,310 | 51,200 |
| TOTAL | $32,380 | $37,230 | $39,920 | $63,770 | $121,750 |
| Total Assets | $76,570 | $86,260 | $44,010 | $123,360 | $223,490 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 60 | 50 | 40 | 770 | 710 |
| Accounts payable and accrued liabilities | 6,380 | 8,150 | 10,250 | 16,080 | 10,020 |
| Accrued Expenses | 2,990 | 3,760 | 3,430 | 0 | 0 |
| Other current liabilities | 4,040 | 6,320 | 7,630 | 5,370 | 5,570 |
| TOTAL | $13,480 | $19,260 | $22,150 | $22,250 | $16,310 |
| Non-Current Liabilities | |||||
| Long Term Debt | 90 | 140 | N/A | 0 | 700 |
| Other Non-Current Liabilities | 11,500 | 11,700 | 10,090 | 9,180 | 19,130 |
| TOTAL | $50,640 | $57,750 | $64,520 | $12,510 | $28,290 |
| Total Liabilities | $64,130 | $77,030 | $86,670 | $34,770 | $44,610 |
| Shareholders' Equity | |||||
| Common Shares | 60,140 | 41,200 | 30,560 | 30,560 | 168,460 |
| Retained earnings | -150,750 | -127,530 | N/A | -42,990 | -10,110 |
| Other shareholders' equity | 103,040 | 95,550 | 93,720 | 21,720 | 14,300 |
| TOTAL | $12,430 | $9,220 | $124,280 | $88,590 | $178,870 |
| Total Liabilities And Equity | $76,560 | $86,250 | $210,950 | $123,360 | $223,480 |